Similar articles

• Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.

  Bioulac B, Fumoux F, Ferron A, Vincent JD. Bioulac B, et al. Eur J Pharmacol. 1978 Sep 1;51(1):29-37. doi: 10.1016/0014-2999(78)90058-4. Eur J Pharmacol. 1978. PMID: 699972
• Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates.

  Roth RH, Bacopoulos NG, Bustos G, Redmond DE Jr. Roth RH, et al. Adv Biochem Psychopharmacol. 1980;24:513-20. Adv Biochem Psychopharmacol. 1980. PMID: 6105797 No abstract available.
• Supersensitivity of caudate neurones after repeated administration of haloperidol.

  Yarbrough GG. Yarbrough GG. Eur J Pharmacol. 1975 Apr;31(2):367-9. doi: 10.1016/0014-2999(75)90062-x. Eur J Pharmacol. 1975. PMID: 1149799
• [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].

  Arushanian EB. Arushanian EB. Farmakol Toksikol. 1982 Sep-Oct;45(5):118-26. Farmakol Toksikol. 1982. PMID: 6128251 Review. Russian. No abstract available.
• Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.

  Glowinski J. Glowinski J. Res Publ Assoc Res Nerv Ment Dis. 1975;54:233-46. Res Publ Assoc Res Nerv Ment Dis. 1975. PMID: 769114 Review. No abstract available.